Koichiro Kanamori
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Interleukin-1α-Mediated Activation of TNF-α/NF-κB Signaling Confers Resistance to Osimertinib in EGFR-Mutant Non-Small-Cell Lung Cancer.
Journal: Thoracic cancer
Published: March 14, 2026
Comparative analysis of the tumor immune microenvironment between thymoma and thymic carcinoma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 03, 2025
Clinical potential of SKP2 as diagnostic marker and therapeutic target in small cell lung cancer.
Journal: Respiratory investigation
Published: January 17, 2024
Anti-Müllerian hormone type II receptor protein expression in non-small cell lung cancer and the effect of AMH/AMHR2 signaling on cancer cell proliferation.
Journal: Thoracic cancer
Published: December 24, 2023
Trophoblast Cell Surface Antigen 2 Expression in Thymic Carcinoma: Brief Report.
Journal: JTO clinical and research reports
Published: December 22, 2023
Multiple Types of Taste Disorders among Patients with COVID-19.
Journal: Internal medicine (Tokyo, Japan)
Published: May 08, 2022
Activation of insulin-like growth factor-1 receptor confers acquired resistance to osimertinib in non-small cell lung cancer with EGFR T790M mutation.
Journal: Thoracic cancer
Published: October 05, 2019
Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-β/Smad pathway.
Journal: Respiratory investigation
Published: August 03, 2019
Malignant Pleural Mesothelioma with Bone Marrow Metastases.
Journal: Internal medicine (Tokyo, Japan)
Published: April 03, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026